Consistent with Amgen's commitment to ensure the availability of accurate, current
information on our products, Amgen provides new data and information, as appropriate, to
those compendia recognized by the U.S. Department of Health and Human Services
Centers for Medicare and Medicaid Services (CMS-Recognized Compendia).

CMS-Recognized Compendia include those currently published compendia identified under
Section 1861(t)(2)(B)(ii)(I) of the Social Security Act, as well as compendia subsequently
identified by CMS: the United States Pharmacopoeia-Drug Information (USP DI®) or its
successor publication [amended in Section 6001 (f)(1) of the Deficit Reduction Act of 2005];
the American Hospital Formulary Service-Drug Information (AHFS DI®); DRUGDEX®;
National Comprehensive Cancer Network (NCCN) Drugs & Biologics Compendium™ and
Clinical Pharmacology©.

Amgen periodically monitors the information contained in CMS-Recognized Compendia and
submits corrections or updates as necessary to ensure that the CMS-Recognized
Compendia are made aware of any published material errors or inaccuracies regarding
Amgen products. Although Amgen does not routinely monitor non-CMS-Recognized
Compendia, to the extent that Amgen becomes aware of any material errors or inaccuracies
regarding Amgen products published in non-CMS-Recognized Compendia, Amgen may also
provide corrections or updates to those publications as necessary.

The Amgen website contains the most accurate and current information regarding Amgen
products. For further information or assistance, please contact Amgen Medical Information at
1-800-77-AMGEN (1-800-772-6436).